Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action

Lina Nordquist1, Fredrik Palm1,2, Bradley T Andresen3,41Department of Medical Cell Biology, Division of Integrative Physiology, Uppsala University, Uppsala, Sweden; 2Georgetown University Medical Center, Department of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washingt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lina Nordquist, Fredrik Palm, Bradley T Andresen
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/a05b2a93806a4164910264d420380353
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a05b2a93806a4164910264d420380353
record_format dspace
spelling oai:doaj.org-article:a05b2a93806a4164910264d4203803532021-12-02T05:28:31ZRenal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action1177-54751177-5491https://doaj.org/article/a05b2a93806a4164910264d4203803532008-09-01T00:00:00Zhttp://www.dovepress.com/renal-and-vascular-benefits-of-c-peptide-molecular-mechanisms-of-c-pep-a2294https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491Lina Nordquist1, Fredrik Palm1,2, Bradley T Andresen3,41Department of Medical Cell Biology, Division of Integrative Physiology, Uppsala University, Uppsala, Sweden; 2Georgetown University Medical Center, Department of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washington, DC, USA; 3University of Missouri, Department of Internal Medicine, Division of Endocrinology, HSC Diabetes Center, Columbia, MO, USA; 4Harry S Truman VA Medical Center, Columbia, MO, USAAbstract: C-peptide has long been thought to be an inert byproduct of insulin production, but it has become apparent, and accepted, that C-peptide has important biological properties. C-peptide displays beneficial effects in many tissues affected by diabetic complications, such as increased peripheral blood flow and protection from renal damage. However, the mechanisms mediating these effects remain unclear. C-peptide interacts with cellular membranes at unidentified sites distinctive of the insulin family of receptors, and signals to multiple targets known to play a role in diabetes and diabetic complications, such as Na+/K+-ATPase and NOS. In general, the physiological and molecular effects of C-peptide resemble insulin, but C-peptide also possesses traits separate from those of insulin. These basic studies have been confirmed in human studies, suggesting that C-peptide may lend itself to clinical applications. However, the molecular and physiological properties of C-peptide are not completely elucidated, and large clinical studies have not begun. In order to further these goals, we critically summarize the current state of knowledge regarding C-peptide’s renal and vascular effects and the molecular signaling of C-peptide.Keywords: C-peptide, insulin, diabetes mellitus, nephropathy, vascular, signaling Lina NordquistFredrik PalmBradley T AndresenDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2008, Iss Issue 3, Pp 441-452 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Lina Nordquist
Fredrik Palm
Bradley T Andresen
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
description Lina Nordquist1, Fredrik Palm1,2, Bradley T Andresen3,41Department of Medical Cell Biology, Division of Integrative Physiology, Uppsala University, Uppsala, Sweden; 2Georgetown University Medical Center, Department of Medicine, Division of Nephrology and Hypertension, Georgetown University, Washington, DC, USA; 3University of Missouri, Department of Internal Medicine, Division of Endocrinology, HSC Diabetes Center, Columbia, MO, USA; 4Harry S Truman VA Medical Center, Columbia, MO, USAAbstract: C-peptide has long been thought to be an inert byproduct of insulin production, but it has become apparent, and accepted, that C-peptide has important biological properties. C-peptide displays beneficial effects in many tissues affected by diabetic complications, such as increased peripheral blood flow and protection from renal damage. However, the mechanisms mediating these effects remain unclear. C-peptide interacts with cellular membranes at unidentified sites distinctive of the insulin family of receptors, and signals to multiple targets known to play a role in diabetes and diabetic complications, such as Na+/K+-ATPase and NOS. In general, the physiological and molecular effects of C-peptide resemble insulin, but C-peptide also possesses traits separate from those of insulin. These basic studies have been confirmed in human studies, suggesting that C-peptide may lend itself to clinical applications. However, the molecular and physiological properties of C-peptide are not completely elucidated, and large clinical studies have not begun. In order to further these goals, we critically summarize the current state of knowledge regarding C-peptide’s renal and vascular effects and the molecular signaling of C-peptide.Keywords: C-peptide, insulin, diabetes mellitus, nephropathy, vascular, signaling
format article
author Lina Nordquist
Fredrik Palm
Bradley T Andresen
author_facet Lina Nordquist
Fredrik Palm
Bradley T Andresen
author_sort Lina Nordquist
title Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
title_short Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
title_full Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
title_fullStr Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
title_full_unstemmed Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
title_sort renal and vascular benefits of c-peptide: molecular mechanisms of c-peptide action
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/a05b2a93806a4164910264d420380353
work_keys_str_mv AT linanordquist renalandvascularbenefitsofcpeptidemolecularmechanismsofcpeptideaction
AT fredrikpalm renalandvascularbenefitsofcpeptidemolecularmechanismsofcpeptideaction
AT bradleytandresen renalandvascularbenefitsofcpeptidemolecularmechanismsofcpeptideaction
_version_ 1718400366608908288